Q Wang1,2, X-D Zhang1, X Liu3, Y-Q Yang4,5. 1. Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, No. 241 West Huaihai Road, 200030, Shanghai, People's Republic of China. 2. Department of Cardiology, Cardiovascular Research Laboratory, and Central Laboratory, Shanghai Chest Hospital, Shanghai Jiaotong University, No. 241 West Huaihai Road, 200030, Shanghai, People's Republic of China. 3. Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, No. 241 West Huaihai Road, 200030, Shanghai, People's Republic of China. xkliuxu@126.com. 4. Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, No. 241 West Huaihai Road, 200030, Shanghai, People's Republic of China. yang99yang66@hotmail.com. 5. Department of Cardiology, Cardiovascular Research Laboratory, and Central Laboratory, Shanghai Chest Hospital, Shanghai Jiaotong University, No. 241 West Huaihai Road, 200030, Shanghai, People's Republic of China. yang99yang66@hotmail.com.
Abstract
BACKGROUND: Renal impairment and atrial fibrillation (AF) often coexist. Catheter ablation is an effective way to reduce the burden of AF and improve symptoms; however, little is known about the relationship between renal function and AF and its role in the progression of AF for patients undergoing repeat catheter ablation. METHODS: In all, 171 patients with long-standing persistent AF ablation were enrolled in the study. The patients were divided into two groups according to their delta estimated glomerular filtration rate (eGFR) values, which was defined as the eGFR before the repeat procedure minus the eGFR before the initial procedure. Patients with decreasing eGFR (delta eGFR < 0) were categorized as group I, while individuals with no change or increasing eGFR (delta eGFR≥ 0) were categorized as group II. eGFR was estimated at baseline and at the 12-month and 24-month follow-up visits. RESULTS: After a mean follow-up of 31.4 ± 13.2 months, group I had a significantly higher arrhythmia recurrence rate than group II (71.2 vs. 49.2 %, p < 0.001). On multivariable analyses, eGFR changes after the repeat procedure were associated with arrhythmia recurrence, hypertrophic cardiomyopathy, and CHA2DS2-VASc score. Patients with arrhythmia recurrence and those with a CHA2DS2-VASc score of ≥ 3 were more likely to show an eGFR decline at follow-up. CONCLUSION: Patients with long-standing persistent AF, with a failed initial ablation procedure and undergoing a repeat ablation procedure, appear to have a higher risk of arrhythmia recurrence. During the follow-up period, patients without arrhythmia recurrence and those with a CHA2DS2-VASc score of < 3 show improved renal function.
BACKGROUND:Renal impairment and atrial fibrillation (AF) often coexist. Catheter ablation is an effective way to reduce the burden of AF and improve symptoms; however, little is known about the relationship between renal function and AF and its role in the progression of AF for patients undergoing repeat catheter ablation. METHODS: In all, 171 patients with long-standing persistent AF ablation were enrolled in the study. The patients were divided into two groups according to their delta estimated glomerular filtration rate (eGFR) values, which was defined as the eGFR before the repeat procedure minus the eGFR before the initial procedure. Patients with decreasing eGFR (delta eGFR < 0) were categorized as group I, while individuals with no change or increasing eGFR (delta eGFR≥ 0) were categorized as group II. eGFR was estimated at baseline and at the 12-month and 24-month follow-up visits. RESULTS: After a mean follow-up of 31.4 ± 13.2 months, group I had a significantly higher arrhythmia recurrence rate than group II (71.2 vs. 49.2 %, p < 0.001). On multivariable analyses, eGFR changes after the repeat procedure were associated with arrhythmia recurrence, hypertrophic cardiomyopathy, and CHA2DS2-VASc score. Patients with arrhythmia recurrence and those with a CHA2DS2-VASc score of ≥ 3 were more likely to show an eGFR decline at follow-up. CONCLUSION:Patients with long-standing persistent AF, with a failed initial ablation procedure and undergoing a repeat ablation procedure, appear to have a higher risk of arrhythmia recurrence. During the follow-up period, patients without arrhythmia recurrence and those with a CHA2DS2-VASc score of < 3 show improved renal function.
Authors: Ayman A Hussein; Walid I Saliba; David O Martin; Mandeep Bhargava; Minerva Sherman; Christina Magnelli-Reyes; Mohammed Chamsi-Pasha; Seby John; Michelle Williams-Adrews; Bryan Baranowski; Thomas Dresing; Thomas Callahan; Mohamed Kanj; Patrick Tchou; Bruce D Lindsay; Andrea Natale; Oussama Wazni Journal: Circ Arrhythm Electrophysiol Date: 2011-04-14
Authors: A Goette; T Staack; C Röcken; M Arndt; J C Geller; C Huth; S Ansorge; H U Klein; U Lendeckel Journal: J Am Coll Cardiol Date: 2000-05 Impact factor: 24.094
Authors: Jie Li; Joseph Solus; Qingxia Chen; Young Hee Rho; Ginger Milne; C Michael Stein; Dawood Darbar Journal: Heart Rhythm Date: 2009-12-24 Impact factor: 6.343
Authors: Jelena Kornej; Gerhard Hindricks; Amitava Banerjee; Arash Arya; Philipp Sommer; Sascha Rolf; Daniela Husser; Gregory Y H Lip; Andreas Bollmann Journal: Heart Date: 2014-10-03 Impact factor: 5.994